These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8277301)

  • 1. Dysfunctional attitudes in major depression. Changes with pharmacotherapy.
    Fava M; Bless E; Otto MW; Pava JA; Rosenbaum JF
    J Nerv Ment Dis; 1994 Jan; 182(1):45-9. PubMed ID: 8277301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunctional attitudes and perceived stress predict depressive symptoms severity following antidepressant treatment in patients with chronic depression.
    Pedrelli P; Feldman GC; Vorono S; Fava M; Petersen T
    Psychiatry Res; 2008 Dec; 161(3):302-8. PubMed ID: 18976817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysfunctional attitudes and personality disorder comorbidity during long-term treatment of MDD.
    Farabaugh A; Mischoulon D; Schwartz F; Pender M; Fava M; Alpert J
    Depress Anxiety; 2007; 24(6):433-9. PubMed ID: 17086540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of dysfunctional attitudes and early maladaptive schemas: a 9-year follow-up study of clinically depressed subjects.
    Wang CE; Halvorsen M; Eisemann M; Waterloo K
    J Behav Ther Exp Psychiatry; 2010 Dec; 41(4):389-96. PubMed ID: 20452570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major depressive subtypes and treatment response.
    Fava M; Uebelacker LA; Alpert JE; Nierenberg AA; Pava JA; Rosenbaum JF
    Biol Psychiatry; 1997 Oct; 42(7):568-76. PubMed ID: 9376453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eighteen months of drug treatment for depression: predicting relapse and recovery.
    Mulder RT; Frampton CM; Luty SE; Joyce PR
    J Affect Disord; 2009 Apr; 114(1-3):263-70. PubMed ID: 18805590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine treatment of nonparaphilic sexual addictions and paraphilias in men.
    Kafka MP; Prentky R
    J Clin Psychiatry; 1992 Oct; 53(10):351-8. PubMed ID: 1429474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficiently assessing negative cognition in depression: an item response theory analysis of the Dysfunctional Attitude Scale.
    Beevers CG; Strong DR; Meyer B; Pilkonis PA; Miller IR
    Psychol Assess; 2007 Jun; 19(2):199-209. PubMed ID: 17563201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine in the treatment of anger: an open clinical trial.
    Rubey RN; Johnson MR; Emmanuel N; Lydiard RB
    J Clin Psychiatry; 1996 Sep; 57(9):398-401. PubMed ID: 9746447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysfunctional attitudes and cognitive schemas in bipolar manic and unipolar depressed outpatients: implications for cognitively based psychotherapeutics.
    Goldberg JF; Gerstein RK; Wenze SJ; Welker TM; Beck AT
    J Nerv Ment Dis; 2008 Mar; 196(3):207-10. PubMed ID: 18340255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in cognitive factors between "true drug" versus "placebo pattern" response to fluoxetine as defined by pattern analysis.
    Farabaugh AH; Sonawalla SB; Fava M; Pedrelli P; Papakostas GI; Schwartz F; Mischoulon D
    Hum Psychopharmacol; 2006 Jun; 21(4):221-5. PubMed ID: 16783809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
    Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of depression and anxiety in infertile women: cognitive behavioral therapy versus fluoxetine.
    Faramarzi M; Alipor A; Esmaelzadeh S; Kheirkhah F; Poladi K; Pash H
    J Affect Disord; 2008 May; 108(1-2):159-64. PubMed ID: 17936366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression.
    Schmidt PJ; Daly RC; Bloch M; Smith MJ; Danaceau MA; St Clair LS; Murphy JH; Haq N; Rubinow DR
    Arch Gen Psychiatry; 2005 Feb; 62(2):154-62. PubMed ID: 15699292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the cognitive mediational model of cognitive behavioural therapy for depression.
    Quilty LC; McBride C; Bagby RM
    Psychol Med; 2008 Nov; 38(11):1531-41. PubMed ID: 18578895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
    Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM
    Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfunctional beliefs in bipolar disorder: hypomanic vs. depressive attitudes.
    Alatiq Y; Crane C; Williams JM; Goodwin GM
    J Affect Disord; 2010 May; 122(3):294-300. PubMed ID: 19773086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoxetine efficacy in social phobia.
    Van Ameringen M; Mancini C; Streiner DL
    J Clin Psychiatry; 1993 Jan; 54(1):27-32. PubMed ID: 8428894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender, type of treatment, dysfunctional attitudes, social support, life events, and depressive symptoms over naturalistic follow-up.
    Zlotnick C; Shea MT; Pilkonis PA; Elkin I; Ryan C
    Am J Psychiatry; 1996 Aug; 153(8):1021-7. PubMed ID: 8678170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.